Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes — Diabetes Care
Links shared publicly online about this topic.
- 486total visits
Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes — Diabetes Care
Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes — Diabetes Care
View full resource at instapaper.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Type 2 Diabetes, Low Blood Sugar, Byetta
Most Recently Shared on February 23, 2011 at 12:07 pm By:
Exenatide is noninferior to insulin for glycemic control but superior for hypoglycemia and weight control: http://bit.ly/fddwvT
Endocrinology Article | Hypoglycemia
mdlinx.com — “Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A randomized 26-week study on glycemic control and hypoglycemia” View full resource at mdlinx.com
Most Recently Shared on February 23, 2011 at 11:39 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabe... http://bit.ly/ieVXNr #endo
Advertisement
